Saturday Longforms: GLP-1s, surgery vs. placebo, nursing homes, medical debt, and bird photos
Three recent articles highlight how shifting views of GLP-1 antiobesity medications. Dani Blum of the New York Times (gift link) reports on a large academic study finding that many people taking GLP-1 medications don’t have a medical indication such as diabetes or obesity. Users were more likely to be female, white, privately insured, and to…

